1 Min Read
* Company has entered into a term sheet agreement with InMed Pharmaceuticals Inc
* Agreement with InMed Pharma for discovery and development of cannabinoid-based therapies targeting kidney diseases Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.